GSK and Spero Therapeutics' oral cabapenem, tebipenem HBr, has become the first antibiotic in the class to show efficacy in a phase 3 trial involving patients with complicated urinary tract infections ...

New research presented at the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global 2026 ...

A randomized trial involving gram-negative bacterial bloodstream infections found that rapid antibiotic susceptibility ...

BV100 is a potential best-in-class anti-infective agent in treating hospital-acquired bacterial pneumonia (HABP) or ventilator-associated bacterial pneumonia (VABP) caused by carbapenem-resistant ...

Meiji Seika Pharma will present 10 studies on Nacubactam at ESCMID Global 2026 including Phase III Integral-2 results in patients with CRE infections.

ESCMID is the premier annual congress of the European Society of Clinical Microbiology and Infectious Diseases. It takes place from April 17 - 21, 2026 in Munich, Germany.

Real-world evidence study carried out in Spain demonstrates 68% clinical cure rate at day 14, and 83% overall survival at day 28, for patients infected with highly resistant metallo-beta lactamase ...

GlaxoSmithKline (GSK) has resubmitted a new drug application (NDA) to the US Food and Drug Administration seeking approval of tebipenem pivoxil hydrobromide (HBr), an investigational oral carbapenem ...

The United States is facing an increase in human infections by drug-resistant bacteria. One such bacteria, called New Delhi metallo-beta-lactamase-producing carbapenem-resistant Enterobacterales, is ...

FRIDAY, Oct. 3, 2025 (HealthDay News) -- From 2019 to 2023, the incidence of carbapenemase-producing carbapenem-resistant Enterobacterales (CP-CRE) increased, mainly due to New Delhi ...

A new CDC report shows that infections caused by multi-drug-resistant bacteria known colloquially as “nightmare bacteria” surged in the United States from 2019 to 2023. Carbapenem-resistant ...

Human infections from drug-resistant bacteria are spiking in the U.S., the Centers for Disease Control and Prevention has warned. The CDC’s laboratory tests have shown that occurrences of a bacteria ...